nevirapine (viramune) Report issue

Small molecule Approved FDA Accelerated Approval FDA Priority Review FDA
AACT ChEMBL DrugBank Drug Central Drugs@FDA KEGG MeSH PubChem repoDB
Back

Drug Pricing Summary

NADAC

$0.1387 - $4.2946

AUS PBS

$1.3223 - $104.6655

VA FSS

$2.8158 - $19.1783

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
nevirapine 10 mg / 1 mL (LIQUID) $104.6655 AUS PBS generic
  • Viramune (1)
    		•  Boehringer Ingelheim Pty Ltd
    nevirapine 200 mg (TABLET) $0.1387 NADAC generic
  • Nevirapine (1)
    		•  Macleods Pharmaceuticals Limited
    nevirapine 200 mg (TABLET) $1.3223 AUS PBS generic
  • Nevirapine Alphapharm (60)
    		•  Alphapharm Pty Ltd
    nevirapine 200 mg (TABLET) $10.4472 VA FSS
  • Viramune (60)
    		•  Boehringer Ingelheim Pharmaceuticals, Inc.
    nevirapine 400 mg (TABLET) $2.6445 AUS PBS generic
  • Viramune XR (30)
    		•  Boehringer Ingelheim Pty Ltd
  • Nevirapine XR APOTEX (30)
    		•  Apotex Pty Ltd
    nevirapine 400 mg (TABLET) $4.2946 NADAC generic
  • Nevirapine (1)
    		•  Sandoz Inc
    nevirapine 400 mg (TABLET) $19.1783 VA FSS
  • Viramune (30)
    		•  Boehringer Ingelheim Pharmaceuticals, Inc.
    nevirapine 50 mg / 5 mL (5 mL SUSPENSION) $2.8158 VA FSS
  • Viramune (48)
    		•  Boehringer Ingelheim Pharmaceuticals, Inc.

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue